Cortechs.ai | Epilepsy Care with NeuroQuant Seizure: The Power of Quantifying Hippocampal Asymmetry

Epilepsy Care with NeuroQuant Seizure: The Power of Quantifying Hippocampal Asymmetry

Epilepsy is one of the most common neurological disorders worldwide, affecting millions of people with unpredictable, life-altering seizures. While advancements in diagnosis and treatment have improved patient outcomes, challenges remain, particularly in assessing the structural brain changes that contribute to seizure activity.

One of the most critical structures involved in epilepsy, especially temporal lobe epilepsy (TLE), is the hippocampus. Structural abnormalities in this region are strongly associated with seizure onset, making precise imaging essential for diagnosis and treatment planning. This is where NeuroQuant Seizure changes the game.

Hippocampal Asymmetry Report: A Key Tool in Epilepsy

NeuroQuant Seizure is an advanced imaging tool that quantifies hippocampal volume and asymmetry, providing objective, data-driven insights for radiologists and neurologists.  By detecting hippocampal atrophy or structural damage, this tool supports clinicians to make more accurate diagnoses and treatment decisions. 

Cortechs.ai | Epilepsy Care with NeuroQuant Seizure: The Power of Quantifying Hippocampal Asymmetry

Here’s how it works:

  • Hippocampal Asymmetry Measurement: The tool quantifies the size difference between the left and right hippocampi, which can often be a sign of brain structural changes due to epilepsy.
  • Automated and Accurate: NeuroQuant Seizure uses advanced image processing algorithms to provide an objective, automated analysis of the MRI scans, improving efficiency and consistency in assessments.
  • Improved Decision-Making: By delivering accurate and consistent data, the hippocampal asymmetry report aids clinicians in making informed decisions regarding diagnosis, treatment options, and surgical considerations when necessary.

Why It Matters for Epilepsy Patients

The ability to detect hippocampal abnormalities early on is a game changer for epilepsy management. By leveraging NeuroQuant Seizure’s hippocampal asymmetry analysis, healthcare providers can:

  • Enhance Diagnosis: Quickly identify structural changes in the brain that could be contributing to seizures, helping to pinpoint the type of epilepsy and its possible causes.
  • Tailor Treatment Plans: With a more accurate understanding of the brain’s structure, treatment plans can be customized to each patient’s specific needs, whether through medication or surgical options like hippocampal resection.
  • Monitor Disease Progression: NeuroQuant Seizure also allows for longitudinal tracking, offering insights into how hippocampal changes evolve over time, helping clinicians assess the effectiveness of treatment interventions.

As neuroimaging technology advances, tools like NeuroQuant Seizure are transforming epilepsy care by delivering objective, high-precision MRI analysis.  By integrating AI-driven insights into clinical workflows, healthcare providers can make more informed decisions, leading to better outcomes for epilepsy patients.  With NeuroQuant Seizure, the future of epilepsy diagnosis and treatment is faster, accurate and more precise, empowering clinicians to provide personalized, data-driven care that makes a lasting impact.  

More Resources

06/23/2026

Helping Our Clients Share Their Success Stories

Learn how Cortechs helps clients share clinical achievements, workflow improvements, and innovation through case studies, testimonials, webinars, and more.

06/15/2026

Alzheimer’s Awareness Month: Bringing Clarity to the Alzheimer’s Care Continuum Through Quantitative Imaging

Explore how quantitative imaging is helping clinicians assess, diagnose, and monitor Alzheimer’s disease and related dementias with greater clarity.

06/08/2026

Cortechs.ai and TAC Center Celebrate One Year of Advancing Neuroimaging Innovation in Peru

TAC Centers Peru is celebrating one year of integrating the NeuroQuant® suite into clinical practice.

06/04/2026

SNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging

At SNMMI 2026, Cortechs.ai showcased NeuroQuant® PET and the growing role of quantitative PET imaging in dementia care.

06/02/2026

Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows

Cortechs.ai and Microsoft are partnering to help bring advanced AI-powered quantitative imaging directly into radiology workflows.

05/26/2026

Cortechs.ai Partners with ARJ Medical to Advance AI-Driven Neuro and Prostate Imaging in the Middle East

Cortechs.ai and ARJ Medical have partnered to expand access to AI-powered neuro and prostate imaging solutions across the Middle East.
Scroll to Top